1. Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial. (February 2022) Authors: Reuter, Uwe; Ehrlich, Marc; Gendolla, Astrid; Heinze, Axel; Klatt, Jan; Wen, Shihua; Hours-Zesiger, Peggy; Nickisch, Jacqueline; Sieder, Christian; Hentschke, Christian; Maier-Peuschel, Monika Journal: Cephalalgia Issue: Volume 42:Number 2(2022) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗